Gro H. Mathisen, Paul Whaley, Birgit Kopainsky, et al. Preparing for CHANGE: How systems thinking supports an effective transition from animal studies to NAMs. NAM Journal. 2026;2:100118. doi:10.1016/j.namjnl.2026.100118
Ronit Mohapatra, Dowlette-Mary Alam El Din, Hanyu Zhao, Thomas Hartung, Lena Smirnova. Towards learning and memory risk assessment with human brain organoids: barriers and opportunities. Frontiers in Toxicology. 2026;8. doi:10.3389/ftox.2026.1783893
Timothy W. Gant, Alistair Boxall, Daniel Burgwinkel, et al. Building trust in the integration of artificial intelligence into chemical risk assessment: findings from the 2024 ECETOC workshop. Archives of Toxicology. 2026. doi:10.1007/s00204-025-04286-8
Yadvinder Bhuller, Marc Avey, Raywat Deonandan, et al. Ethical principles for regulatory risk decision-making. Regulatory Toxicology and Pharmacology. 2025:105813. doi:10.1016/j.yrtph.2025.105813
Thomas Hartung. The turning point: April 2025 marks historic shift in US animal testing policy. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2504301
Thomas Hartung, Lena Smirnova. A path forward advancing microphysiological systems. ALTEX - Alternatives to animal experimentation. 2025;42(2):183-203. doi:10.14573/altex.2504091
Eike Cöllen, Kristina Bartmann, Jonathan Blum, et al. Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2501091
Jonathan Blum, Markus Brüll, Jan G. Hengstler, et al. The long way from raw data to NAM-based information: Overview on data layers and processing steps. ALTEX - Alternatives to animal experimentation. 2025;42(1):167-180. doi:10.14573/altex.2412171
Thomas Hartung, Maurice Whelan, Weida Tong, Robert M. Califf. Is regulatory science ready for artificial intelligence? npj Digital Medicine. 2025;8(1):1-5. doi:10.1038/s41746-025-01596-0